. Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration. J Biol Chem. 2015 Aug 7;290(32):19433-44. Epub 2015 Jun 15 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Research Models

  1. LRRK2 G2019S Rat (BAC Tg)

Therapeutics

  1. DNL151
  2. DNL201

News

  1. LRRK2 Inhibitor Hits Target, Appears Safe for Parkinson’s